Alto Neuroscience Stock (NYSE: ANRO) stock price, news, charts, stock research, profile.
You can purchase shares of Alto Neuroscience (NYSE:ANRO) through any online brokerage.
Other companies in Alto Neuroscience’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Rani Therapeutics Hldgs (NASDAQ:RANI), Nutriband (NASDAQ:NTRB), Telomir Pharmaceuticals (NASDAQ:TELO) and Trevi Therapeutics (NASDAQ:TRVI).
Alto Neuroscience has a consensus price target of $20.00.
The stock price for Alto Neuroscience (NYSE: ANRO) is $4.1001 last updated November 20, 2024 at 4:36 PM EST.
There are no upcoming dividends for Alto Neuroscience.
Alto Neuroscience’s Q4 earnings are confirmed for Sunday, February 2, 2025.
There is no upcoming split for Alto Neuroscience.
Alto Neuroscience is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.